Inventor

Catherine R. Kostlan

Inventor
Saline, MI, US

Overview

41→
Patents
1989–2013
Patent span
Chemistry
Primary field (CPC C)

Patents· 41 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds49%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
A61KPreparations for medical, dental or toiletry purposes7%
C07CAcyclic or carbocyclic compounds7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C07KPeptides4%
A61QSpecific use of cosmetics or similar toiletry preparations3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
Y02PClimate change mitigation technologies in the production or processing of goods3%
PatentTitleYear
8,409,595'Method for decreasing sebum production'20137,615,230'Method for decreasing sebum production'20096,894,057'Oxo-azabicyclic compounds'20056,316,415'Sulfonamide interleukin-1.beta. converting enzyme inhibitors'20015,932,549'N-substituted glutamic acid derivatives with interleukin-1.beta. converting enzyme inhibitory activity'19995,744,451'N-substituted glutamic acid derivatives with interleukin-1 .beta. converting enzyme inhibitory activity'19985,432,181'Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents'19955,376,670'3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents'19945,356,898'Substituted 4,6-di-tertiary-butyl 5-hydroxy-pyrimidines'19945,348,957'5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents'19945,340,815'2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents'19945,338,737'Biphenyl oxadiazoles and thiadiazoles as angiotensin II antagonists'19945,312,821'2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents'19945,302,597'2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents'19945,284,949'2-substituted amino-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines as antiinflammatory agents'19945,270,319'5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents'19935,256,680'3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxy-phenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents'19935,248,682'2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents'19935,240,929'2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents'19935,220,025'2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents'19935,215,986'5-hydroxy-2-pyrimidinylmethylene oxaza heterocycles'19935,212,189'Thiadiazole or oxadiazole analogs of fenamic acids containing substituted hydroxamate side chains as antiinflammatory agents'19935,210,204'Biphenyl oxadiazoles and thiadiazoles as angiothesin II antagonists'19935,208,251'Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxygenase inhibitors, pharmaceutical compositions and methods of use therefor'19935,196,431'2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents'19935,187,175'2-carbonyl substituted-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents'19935,177,079'2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents'19935,155,122'3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxy-phenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents'19925,143,929'2-substituted thiazolidinone, oxazolidinone, and imidazolidinone derivatives of fenamates as antiinflammatory agents'19925,112,846'N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents'19925,102,897'3,5-ditertiarybutyl-4-hydroxyphenyl, 1,3,4-thiadiazoles and oxadiazoles linked by carbon, oxygen, and sulfur residues'19925,102,879'Method of treating gout with novel 9-deazaguanines'19925,101,030'9-deazaguanines'19925,075,330'N-hydroxyamide, N-hydroxythioamide, N-hydroxyurea, and N-hydroxythiourea derivatives of selected NSAIDS as antiinflammatory agents'19915,061,707'9-deazaguanines to treat psoriasis'19915,017,604'Novel fenamic acid methyl hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition'19914,988,702'Novel 9-deazaguanines'19914,981,865'N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents'19914,923,872'Analogues of pyrrolo[3,2d]pyrimidin-4-ones'19904,924,002'Novel process for the preparation of pyrazoles from isoxazoles'19904,877,881'Process of preparing pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxygenase inhibitors'1989

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1989–2005Patents assigned to WARNER LAMBERT CO (39)· patent assignee history
1989–1993Based in Ann Arbor, MI, US· patent location history
1991–2013Based in Saline, MI, US· patent location history
1998–2001Patents assigned to BASF AG (3)· patent assignee history
2009Patents assigned to GRACEWAY PHARMACEUTICALS LLC (1)· patent assignee history
2013Patents assigned to KOSTLAN CATHERINE R (1)· patent assignee history
2013Patents assigned to MEDICIS PHARMACEUTICAL CORP (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
WARNER LAMBERT CO391989–2005
BASF AG31998–2001
GRACEWAY PHARMACEUTICALS LLC12009
KOSTLAN CATHERINE Rself12013
MEDICIS PHARMACEUTICAL CORP12013
Locations
LocationPatentsSpan
Saline, MI, US331991–2013
Ann Arbor, MI, US81989–1993